Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
5.73
-0.07 (-1.21%)
Jun 18, 2025, 4:00 PM - Market closed
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
$1,088,459
Profits / Employee
-$58,864
Market Cap
1.76B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FOLD News
- 3 days ago - The Association of American Physicians and Surgeons files an Amicus Brief in the Supreme Court in Support of the Right to Conversion Therapy - GlobeNewsWire
- 6 days ago - In NCLA Amicus Win, Supreme Court Revives Innocent Family's Suit over FBI's Wrong-House Raid - GlobeNewsWire
- 7 days ago - In NCLA Amicus Win, District Court Topples Kansas Dog Kennel No-Warrant Inspection Regime - GlobeNewsWire
- 7 days ago - Amicus Therapeutics: Opportunity Awaits In This Beaten Down Pharma - Seeking Alpha
- 16 days ago - New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve - GlobeNewsWire
- 20 days ago - Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 - GlobeNewsWire
- 6 weeks ago - Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference - GlobeNewsWire
- 7 weeks ago - Amicus Therapeutics, Inc. (FOLD) Q1 2025 Earnings Call Transcript - Seeking Alpha